書誌事項
- タイトル別名
-
- The Effectiveness of Nasal Nebulizer Therapy with Cefmenoxime Hydrochloride and Nasal Drops of Povidone Iodine for Acute Rhinosinusitis in Children
- リンショウ ビフクビクウエン ケンシュツキン ニ タイスル キョクショ リョウホウ ノ コウカ ベストロン イソジン オ モチイテ
- ベストロン<sup>®</sup>, イソジン<sup>®</sup>を用いて
この論文をさがす
抄録
We clinically studied the effectiveness of nasal nebulizer therapy with cefmenoxime hydrochloride (CMX) and nasal drops of povidone iodine for acute rhinosinusitis in children. We evaluated the results using the standard for new antibiotics of the Japanese Society of Chemotherapy. The subjects were 50 children with acute rhinosinusitis. By the standard for total evaluation, consisting of clinical and bacteriological study, the cure rate of the CMX nebulizer group was 68%, that of the group using nasal drops of povidone iodine was 23.1%, and that of the controls was 38.5%. The cure rate with nasal drops of povidone iodine was not higher than that with CMX nebulizer therapy. However, with the nasal drops of povidone iodine, in 2 of 3 cases, PISP (penicillin intermediately resistant S. pneumoniae) disappeared and in 2 of 2 cases, MRSA (methicillin-resistant S. aureus) disappeared. The nasal drops of povidone iodine were found to be effective for drug-resistant organisms such as PISP and MRSA.
収録刊行物
-
- 耳鼻咽喉科臨床
-
耳鼻咽喉科臨床 97 (7), 599-604, 2004
耳鼻咽喉科臨床学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390001204263170944
-
- NII論文ID
- 10013295921
-
- NII書誌ID
- AN00107089
-
- ISSN
- 18844545
- 00326313
-
- NDL書誌ID
- 7018070
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可